Research progress on lipid nanoparticle messenger RNA delivery system.
10.3724/zdxbyxb-2024-0709
- Author:
Shun HE
1
;
Shuai LIU
2
Author Information
1. College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China. shunhe@zju.edu.cn.
2. College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China. shuailiu@zju.edu.cn.
- Publication Type:English Abstract
- Keywords:
Gene therapy;
Lipid nanoparticle;
Messenger RNA delivery system;
Messenger RNA therapy;
Review;
Targeted delivery
- MeSH:
Humans;
RNA, Messenger/administration & dosage*;
Nanoparticles/chemistry*;
Lipids/chemistry*;
Drug Delivery Systems;
Animals;
Liposomes
- From:
Journal of Zhejiang University. Medical sciences
2025;54(4):446-454
- CountryChina
- Language:Chinese
-
Abstract:
Messenger RNA (mRNA) therapeutics involve delivering in vitro transcribed mRNA into specific cells to produce target proteins for the treatment or prevention of diseases. However, the development of mRNA therapeutics relies largely on mRNA delivery systems. Lipid nanoparticles (LNPs) represent the most widely used mRNA carriers in clinical applications. Composed of ionizable lipids, zwitterionic phospholipids, cholesterol, and polyethylene glycol-lipids, LNPs can address critical challenges in mRNA drug development, such as poor in vivo stability and the difficulty in crossing biological barriers. Ultimately, LNPs enable safe, efficient, and targeted mRNA delivery to the liver, lung, spleen, and other organs. This review outlines the roles of the four lipid components in LNPs for mRNA delivery. It then introduces targeted mRNA delivery to various organs/tissues such as the liver, lung, spleen, pancreas, bone marrow, and placenta, using strategies such as antibody modification, lipid structure alteration, and specialized administration routes. Additionally, this review discusses the applications and challenges of LNP-based mRNA therapeutics in disease treatment, aiming to provide insights for the clinical translation of mRNA therapies and for further innovations in LNP delivery systems.
